Oncology and cancer therapeutics experts

Builds microfluidic tumor models and microneedles that modulate the tumor microenvironment for CAR-T therapy.

Studies hepatocellular carcinoma mechanisms and short-chain fatty acid therapeutics for cancer and chronic inflammation.

Reformulates a widely used oncology therapy to reduce solvent-related toxicity.

Designs self-oxygenating nanoformulations and closed-loop hardware for theranostics of hypoxic tumors.

Tests intratumoral glatiramer acetate injection in patients with percutaneously accessible tumors.

Builds fructose-based probes to screen GLUT5 transporter inhibitors in breast cancer cells.

Develops peptide-drug conjugates that reprogram tumor-associated macrophages in breast cancer.

Develops microbubble flotation for T cell isolation, activation and expansion in CAR-T manufacturing.

Develops a CD206 agonist that activates tumor-associated macrophages to boost antitumor immunity.